Company

Defence Therapeutics, Inc.

Headquarters: Vancouver, BC, Canada

CEO: Mr. Sebastien Plouffe

CSE: DTC +1.69%

Detailed Description

Defence Therapeutics Inc., a biotechnology company, engages in the research and development of biological/biosimilar therapeutic drugs for cancer and infectious diseases. Its proprietary platform is the ACCUMTM technology, which enables precision delivery of vaccine antigens or ADCs in their intact form to target cells. The company focuses on developing dendritic cell cancer vaccines; protein-based vaccine formulation against COVID and infectious diseases; and antibody drug conjugates (ADC) products targeting various cancers. The company was formerly known as Accum Therapeutics Inc. and changed its name to Defence Therapeutics Inc. in March 2020. Defence Therapeutics Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Defence Therapeutics, Inc. has the following listings and related stock indices.


Stock: CSE: DTC wb_incandescent

Details

Headquarters:

1680 – 200 Burrard Street

Vancouver, BC V6C 3L6

Canada

Phone: 514 947 2272